What can be done to control the placebo response in clinical trials? A narrative review

Contemp Clin Trials. 2021 Aug:107:106503. doi: 10.1016/j.cct.2021.106503. Epub 2021 Jul 6.

Abstract

The desire to reduce high placebo response rates in clinical trials is a popular concept. However, few studies have rigorously examined the effectiveness of methods to control for placebo responses that are relevant to randomized controlled trials. The primary objective of this review was to evaluate the effect of experimental placebo manipulations in randomized controlled trials (RCTs). We critically reviewed studies designed to manipulate placebo responses including positive expectations regarding the effectiveness of the placebo treatment, manipulating the time spent with subjects, and training study staff and subjects to accurately report symptom severity. These efforts have generally resulted in reduced placebo response and improved discrimination between drug and placebo. Interventions that neutralize staff and subject expectations and improve the ability of subjects to accurately report symptom severity have shown the most promise. Reduction of the placebo response has the potential to accelerate the development of new therapeutics.

Keywords: Expectation measurements; Placebo effect; Placebo response; Randomized controlled trials; Training.

Publication types

  • Review

MeSH terms

  • Humans
  • Placebo Effect*